Skip to main content
👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources. Claim this profile →
Dr Constantine Alifrangis
Trust score 8/100 Accepting new patients

Dr

Dr Constantine Alifrangis

Oncology

English
10,757+ Patients seen
7 Years in practice
5 Publications
1 Languages spoken

About

Dr Constantine Alifrangis is a Consultant Medical Oncologist in London. He specialises in the treatment of urological cancers including prostate, bladder, testicular and penile cancer.

He graduated from Guys' Kings and St Thomas' Medical school and was awarded the University Gold Medal for medicine. Following this, he completed his postgraduate medical training in oncology at Imperial College London. He undertook research into advanced prostate cancer at Hammersmith Hospital, and was awarded a Wellcome Trust fellowship to research the link between cancer genetics and the efficacy of novel therapies. He was awarded a PhD by the University of Cambridge in 2014 for this work. He was also awarded the Sylvia Lawler prize by the Oncology section of the Royal Society of Medicine.

In 2016, he was appointed Consultant Medical Oncologist at University College London Hospital and St Bartholomew's. He is the Lead Oncologist for Testicular Cancer, treating patients with advanced prostate cancer and is part of a specialist team looking after patients with penile cancer.

He is actively involved in research into the genetic basis of cancer and drug resistance, including personalised approaches to cancer treatment. He is also the Lead Investigator for number of clinical studies looking at rarer and understudied cancers. He has presented his research at a number of international conferences and published research in various cancer journals including the Lancet, Journal of Clinical Oncology, and Clinical Cancer Research.



Diseases, Medical Tests and Treatments
• Chemotherapy

• Bladder Cancer

• Genito-urinary Cancer

• Penile Cancer

• Prostate Cancer

• Testicular Cancer

“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”

— Dr Constantine Alifrangis

Education & training

  1. 2009–2015 MD · Medicine and Surgery
    Universitat de Barcelona (GB)
  2. 2015–2019 Residency · Oncology
    Universidad de Navarra (GB)

Career & appointments

  1. 2019-09–2020-08 Junior consultant
    Universitat de Barcelona Teaching Hospital — Oncology

Licenses & insurance

Medical licenses

GB — Organización Médica Colegial de España (OMC)
#GB-118231 active · expires 2028-12-31

Board certifications

European Board of Oncology
#EB-8E49A29A · issued 2020 · renewal 2030
Malpractice insurance: Allianz Professional · 3,000,000 EUR coverage · No claims on file

Procedures performed

ProcedureCodeLifetime count
GP consultation 99213 2,263
Annual physical exam 99395 977
Vaccination administration 90471 281
Minor procedure (skin) 17110 1,878

Services & pricing

ServiceDurationModalityPrice
New patient consultation (60m) 60 min in_clinic|telemed 180.00 EUR
Follow-up consultation (30m) 30 min in_clinic|telemed|phone 90.00 EUR
Vaccination administration 90 min in_clinic 630.00 EUR
Minor procedure (skin) 60 min in_clinic 720.00 EUR

Office, team & in practice

Constantine Alifrangis
HEADSHOT
Constantine Alifrangis in consultation
IN OFFICE
Constantine Alifrangis with the team
WITH TEAM
Constantine Alifrangis at a conference
CONFERENCE

Videos

introduction · 100s
Meet Constantine Alifrangis

Research & publications

h-index: 8 · i10: 15

  1. Long-term follow-up of Oncology across GB
    Constantine Alifrangis, et al. · European Journal of Medicine, 2026
    DOI: 10.8256/euroclin.2026.0 · PMID: 39626070 · cited by 191
  2. Validation of clinical scoring in Oncology
    Constantine Alifrangis, et al. · European Journal of Medicine, 2025
    DOI: 10.8278/euroclin.2025.1 · PMID: 37341846 · cited by 125
  3. Long-term follow-up of Oncology across GB
    Constantine Alifrangis, et al. · European Journal of Medicine, 2024
    DOI: 10.8848/euroclin.2024.2 · PMID: 31303454 · cited by 11
  4. Validation of clinical scoring in Oncology
    Constantine Alifrangis, et al. · European Journal of Medicine, 2023
    DOI: 10.1051/euroclin.2023.3 · PMID: 30148552 · cited by 105

Invited talks

  • Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
  • Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract

Awards & memberships

Awards

  • 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional

Society memberships

  • WONCA Europe — Family Doctors — Member · since 2020
  • national college of family doctors — Member · since 2020
  • European Union of Medical Specialists (UEMS) — Member · since 2020

Patient reviews

★ 0.00 3,243 verified reviews
Bedside Manner
0.05
Knowledge
0.08
Wait Time
3.80
Staff Friendliness
0.02
Ease Of Appointment
4.00
Value For Money
4.10
Would Recommend Pct
4
  • ★ 5 verified visit

    “Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”

    — Anna B. · 2026-05-11

  • ★ 5 verified visit

    “Took time to listen and reviewed all my previous results. I would absolutely recommend.”

    — Marco V. · 2026-04-26

  • ★ 4 verified visit

    “Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”

    — Helena F. · 2026-04-13

Articles by this doctor

  • Patient education Patient guide to Oncology
  • Awareness When should you see a oncology?

For international patients

Coordinator
Patient liaison · dr.constantine.alifrangis@euroclinics.example

Similar specialists

Browse all →